CorVel Corp. (NASDAQ:CRVL – Get Free Report) Director R Judd Jessup sold 1,262 shares of the company’s stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $70.64, for a total transaction of $89,147.68. Following the sale, the director directly owned 115,821 shares of the company’s stock, valued at $8,181,595.44. This represents a 1.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
R Judd Jessup also recently made the following trade(s):
- On Wednesday, August 26th, R Judd Jessup sold 1,562 shares of CorVel stock. The shares were sold at an average price of $70.71, for a total transaction of $110,449.02.
CorVel Stock Up 0.3%
Shares of NASDAQ:CRVL traded up $0.23 during midday trading on Friday, hitting $69.66. The stock had a trading volume of 42,589 shares, compared to its average volume of 218,616. The company’s 50-day moving average price is $63.19 and its 200-day moving average price is $58.14. The company has a market capitalization of $3.55 billion, a P/E ratio of 30.96 and a beta of 0.98. CorVel Corp. has a fifty-two week low of $44.83 and a fifty-two week high of $93.45.
Institutional Trading of CorVel
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Walleye Capital LLC bought a new stake in CorVel during the 2nd quarter worth $3,308,000. NewEdge Wealth LLC acquired a new stake in shares of CorVel during the second quarter valued at about $1,956,000. OneDigital Investment Advisors LLC bought a new stake in shares of CorVel during the second quarter worth about $1,101,000. Callan Family Office LLC bought a new stake in shares of CorVel during the second quarter worth about $3,833,000. Finally, Deutsche Bank AG acquired a new position in shares of CorVel in the second quarter valued at approximately $3,772,000. Institutional investors own 51.36% of the company’s stock.
Analyst Ratings Changes
A number of brokerages have weighed in on CRVL. Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Weiss Ratings upgraded CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, CorVel currently has an average rating of “Hold”.
Check Out Our Latest Report on CorVel
CorVel Company Profile
CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.
The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).
Recommended Stories
- Five stocks we like better than CorVel
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
